ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,184,000 | +1.8% | 800,000 | 0.0% | 1.61% | +97.4% |
Q4 2022 | $8,040,000 | +2.1% | 800,000 | 0.0% | 0.82% | +31.0% |
Q3 2022 | $7,872,000 | +1.1% | 800,000 | 0.0% | 0.62% | -0.3% |
Q2 2022 | $7,788,000 | -0.1% | 800,000 | 0.0% | 0.62% | +37.1% |
Q1 2022 | $7,792,000 | +0.7% | 800,000 | 0.0% | 0.46% | -5.2% |
Q4 2021 | $7,737,000 | -1.6% | 800,000 | 0.0% | 0.48% | -12.9% |
Q3 2021 | $7,864,000 | – | 800,000 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atalaya Capital Management LP | 500,000 | $4,915,000 | 0.75% |
MMCAP International Inc. SPC | 800,000 | $7,864,000 | 0.55% |
Arena Capital Advisors, LLC- CA | 600,000 | $5,868,000 | 0.46% |
683 Capital Management, LLC | 1,199,000 | $11,786,000 | 0.46% |
SPRING CREEK CAPITAL LLC | 800,000 | $7,824,000 | 0.38% |
DG Capital Management, LLC | 175,000 | $1,720,000 | 0.35% |
FIR TREE CAPITAL MANAGEMENT LP | 1,000,000 | $9,830,000 | 0.33% |
Fortress Investment Group LLC | 519,489 | $5,106,000 | 0.29% |
Exos Asset Management LLC | 55,000 | $531,000 | 0.28% |
ANGELO GORDON & CO., L.P. | 300,000 | $2,949,000 | 0.16% |